Johnson & Johnson (JNJ) — What Changed
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech s…
BestStocks surfaces only meaningful changes—backed by price, volume, catalysts, and peer context—so you can focus on what matters.
1. What Changed Since Last Close
Johnson & Johnson (JNJ) filed an 8-K on April 28, 2026, with no price movement recorded (0%) over the interval.
JNJ rose 3.99% to $254.66 on above-average intraday volume (16.2M shares). The European Medicines Agency's Committee for
EMA's CHMP recommends approval of JNJ's TECVAYLI plus daratumumab for relapsed/refractory multiple myeloma.
JNJ traded at $255.98, up 0.52% from previous close of $254.66. The stock reached a new 52-week high on June 29, 2026.
Johnson & Johnson moved +1.61% from $241.00 to $244.88 on 2026-06-25, reaching a new 30-day high. We checked news, earni
2. Change Timeline
| Date | Change | Price Reaction | Volume | Confidence ↓ |
|---|---|---|---|---|
| Apr 28 | FNew Filing | — | — | Medium |
| Jun 26 | VPrice Move Up | +3.99% | 1.32x | Medium |
| Jun 26 | NNews | +3.99% | 1.32x | Medium |
| Jun 29 | VPrice Move Up | — | — | Low |
| Jun 25 | VPrice Move Up | +1.61% | 0.82x | Low |
3. Why It Moved
- JNJ rose 3.99% to $254.66 on above-average intraday volume (16.2M shar
- JNJ traded at $255.98, up 0.52% from previous close of $254.66. The st
- Johnson & Johnson moved +1.61% from $241.00 to $244.88 on 2026-06-25,
4. Peer / Sector Confirmation
| Symbol | Today | 5D | Rel. Vol | |
|---|---|---|---|---|
| JNJ | +0.81% | — | 0.36x | Leader |
| LLY | +7.13% | — | — | |
| UNH | +2.97% | — | — | |
| PFE | +2.62% | — | — | |
| ABBV | +4.20% | — | — | |
| MRK | +2.56% | — | — |
5. SEC Filing Watch
6. Analyst Expectations
7. Bull vs Bear Thesis Shift
8. What To Watch Next
| Date | Event | Impact | |
|---|---|---|---|
| Jul 15 | Earnings Release | High | |
| Jul 22est. | 10-Q Filing | Medium |